Europe


Flora Growth Closes Acquisition of Franchise Global Health, Cementing Foothold in Germany and the European Union

December 27th, 2022 - Ryan Allway

The transformative acquisition is expected to connect Flora Growth’s Colombian-grown cannabis directly with German-based pharmaceutical and medical cannabis distribution. The deal establishes a foothold in Germany allowing for medical cannabis sales across 1,200+ pharmacies and the distribution of pharmaceutical products across 28 countries. The deal also provides additional upside to Flora should Germany legalize adult-use, […]

Canonic Advances its Penetration into Europe by Signing its First Licensing Agreement with GroVida

September 13th, 2022 - Ryan Allway

Portugal-based GroVida licenses two of Canonic’s cannabis varieties for cultivation and commercialization in Europe   Rehovot, Israel – September 13, 2022 – Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), announced today that it has signed a non-exclusive licensing agreement with […]

Akanda Bolsters Leadership Team to Scale Medical Cannabis Platform Across Europe

August 24th, 2022 - Ryan Allway

Tom Flow Named Chief Operating Officer and Steven George Named Commercial Director   LONDON, August 24, 2022–(BUSINESS WIRE)–International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced that it has appointed Tom Flow to the role of Chief Operating Officer of Akanda and Managing Director of Holigen, and Steven George […]

Akanda Completes Acquisition of Holigen, Advancing Cannabis Leadership Position in Europe, the Middle East and Africa (EMEA)

May 2nd, 2022 - Ryan Allway

Adds prized cultivation, manufacturing and distribution assets and an award-winning genetics library, accelerating Akanda’s seed-to-patient model   May 02, 2022 07:00 AM Eastern Daylight Time LONDON–(BUSINESS WIRE)–International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has closed the acquisition of Holigen Limited (“Holigen”) from The Flowr Corporation (“Flowr”) (TSXV: […]

Flora Growth to Expand Physical Presence in Europe Through JustCBD Partnership with Greenyard

March 23rd, 2022 - Ryan Allway

Flora’s recently acquired JustCBD brand to open four brick-and-mortar locations in 2022 in Germany and the Czech Republic, with additional store openings planned in 2023.   The locations will be managed in partnership with German-based Greenyard and are currently under construction, with store openings expected in Q2 2022.   JustCBD’s product portfolio will be distributed […]

Canonic Announces Shipment of its Cannabis Varieties to Europe

January 31st, 2022 - Ryan Allway

Canonic is the first Israeli company shipping cannabis varieties from Israel to Europe, towards planned commercial launch in Europe in 2023   Rehovot, Israel – January 31, 2022 – Canonic Ltd., focused on the development of medical grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN), announced today that it has shipped a […]

Hebrew University and TechforCann Europe Accelerator to Collaborate on Funding Medical Cannabis Research Companies Worldwide

January 14th, 2022 - Ryan Allway

JERUSALEM, ISRAEL… January 14, 2022 — The Hebrew University of Jerusalem’s (HU) Technology Transfer Company, Yissum, together with the TechforCann Europe Accelerator, announces a strategic collaboration with TechforCann, Europe’s first medical cannabis tech accelerator, to fund startups around the world.   Researchers at HU’s Multidisciplinary Center for Cannabinoid Research, (MCCR) will serve as advisory board members, mentors, and potential candidates for the startups that are accepted into the TechforCann Europe Accelerator program. The HU Medical Cannabis online curriculum will also be available to international audiences through the […]

How to Capitalize on Germany’s Move to Legalize Cannabis

November 30th, 2021 - Ryan Allway

Germany’s incoming governing parties recently announced a formal agreement to legalize adult-use cannabis when they take power. While personal possession has already been decriminalized, the new proposal seeks to establish a regulated market for adult-use cannabis. The move could create an industry like those in Canada and some U.S. states. While the legislation won’t be […]

Khiron Reports Q3 Results – Revenue Increased 83% YoY, 26% QoQ

November 22nd, 2021 - Ryan Allway

Q3 2021 revenue increased 83% YoY to $3.5 million compared to the previous year Gross profit before changes in FV in Q3 2021 increased 62% sequentially to $1.7 million Medical cannabis revenues increased 46% sequentially to $1.2 million Continued strong gross margins for medical cannabis segment at 89%   TORONTO, Nov. 22, 2021 /PRNewswire/ – Khiron Life Sciences Corp. (“Khiron” or […]

Tilray Expands Medical Cannabis Footprint in Europe

October 26th, 2021 - Ryan Allway

— Earns Status as Trusted Supplier of GMP-Certified Medical Cannabis to Luxembourg Ministry of Health — — Tilray Branded Medical Cannabis Now Available in 20 Countries Around the World —   NEW YORK–(BUSINESS WIRE)–Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY), a global pioneer in medical cannabis research, cultivation, production, and distribution, today announced it has […]

PharmaDrug’s Super Smart Launches Slim MycoWeRx Brand of Functional Mushrooms

September 23rd, 2021 - Ryan Allway

Toronto, Ontario–(Newsfile Corp. – September 23, 2021) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (“PharmaDrug” or the “Company“) a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that its Super Smart division is launching its […]

Sanity Group Closes $44.2M Series A

June 15th, 2021 - Ryan Allway

Largest European Cannabis Funding Round to Date   BERLIN, June 15, 2021 /PRNewswire/ – Berlin-based cannabis start-up Sanity Group announced today it has closed a $44.2M USD Series A financing round with new investment led by Swiss venture capital firm Redalpine along with US-based Navy Capital and SOJE Capital. GMPVC also participated in the round.   This represents the largest round of […]

Exclusive Interview with Wildflower Brands CEO: Health and Wellness Cannabis Products

June 19th, 2019 - Ryan Allway

Wildflower Brands (CSE: SUN, OTC: WLDFF) is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products. All of the company’s brands work in synergy toward becoming a global wellness leader. Wildflower distributes products across North America through the regulated cannabis markets as well as through nutraceutical channels, and the […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading